David A Loewenstein
Overview
Explore the profile of David A Loewenstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
135
Citations
2204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zheng D, Cid R, Ortega A, Crocco E, Vaillancourt D, Armstrong M, et al.
Int Psychogeriatr
. 2025 Mar;
37(2):100005.
PMID: 40086908
Objectives: To evaluate the predictive utility of proactive semantic interference (PSI) and failure to recover from proactive semantic interference (frPSI) deficits on the longitudinal everyday functional decline on the Clinical...
2.
Zheng D, Lee D, Rundek T, Lam B, Gregori N, Curiel R, et al.
Am J Ophthalmol
. 2025 Mar;
PMID: 40054544
Purpose: Visual impairment (VI) is prevalent in older adults and associated with cognitive decline. However, the mechanisms through which visual impairment affects cognitive functioning during the aging process are poorly...
3.
Sierra L, Kaur J, Frank S, Halko M, Cid R, Loewenstein D, et al.
Front Neurol
. 2025 Mar;
16:1494816.
PMID: 40046671
Background And Objectives: Huntington's disease (HD) is characterized by progressive cognitive decline, with early deficits often preceding motor symptoms. The Loewenstein-Acevedo Scales for Semantic Interference and Learning (LASSI-L) captures many...
4.
Asken B, Cid R, Crocco E, Armstrong M, Levy S, Arias F, et al.
J Prev Alzheimers Dis
. 2025 Jan;
12(1):100011.
PMID: 39800468
Background: Mild cognitive impairment (MCI) is a clinical diagnosis representing early symptom changes with preserved functional independence. There are multiple potential etiologies of MCI. While often presumed to be related...
5.
Burke S, Barker W, Grudzien A, Greig-Custo M, Behar R, Rodriguez R, et al.
J Appl Gerontol
. 2024 Dec;
:7334648241302159.
PMID: 39657694
Attrition is a significant methodological concern in longitudinal studies. Sample loss can limit generalizability and compromise internal validity. Wave one ( = 346) and wave two follow-ups ( = 196)...
6.
Torres V, Rosselli M, Loewenstein D, Lang M, Velez-Uribe I, Arruda F, et al.
Biling (Camb Engl)
. 2024 Oct;
25(2):337-356.
PMID: 39431281
We examined the association between bilingualism, executive function (EF), and brain volume in older monolinguals and bilinguals who spoke English, Spanish, or both, and were cognitively normal (CN) or diagnosed...
7.
Cid R, Ortega A, Vaillancourt D, Asken B, Crocco E, Armstrong M, et al.
J Alzheimers Dis
. 2024 Oct;
101(4):1195-1204.
PMID: 39392602
Background: Semantic intrusion errors (SIEs) are both sensitive and specific to PET amyloid-β (Aβ) burden in older adults with amnestic mild cognitive impairment (aMCI). Objective: Plasma Aβ biomarkers including the...
8.
Wang W, Asken B, DeSimone J, Levy S, Barker W, Fiala J, et al.
Ageing Res Rev
. 2024 Sep;
101:102507.
PMID: 39306249
Neuroimaging and biofluid biomarkers provide a proxy of pathological changes for Alzheimer's disease (AD) and are useful in improving diagnosis and assessing disease progression. However, it is not clear how...
9.
Cid R, Ortega A, Visser U, Kitaigorodsky M, Zheng D, Hincapie D, et al.
Adv Alzheimer Dis
. 2024 Jul;
13(1):11-25.
PMID: 39035045
Proactive Semantic Interference (PSI) and failure to recover from PSI (frPSI), are novel constructs assessed by the LASSI-L. These measures are sensitive to cognitive changes in early Mild Cognitive Impairment...
10.
Asken B, DeSimone J, Wang W, McFarland K, Arias F, Levy S, et al.
Alzheimers Dement (Amst)
. 2024 Jul;
16(3):e12617.
PMID: 39021585
Introduction: Commercially available plasma p-tau217 biomarker tests are not well studied in ethnically diverse samples. Methods: We evaluated associations between ALZPath plasma p-tau217 and amyloid-beta positron emission tomography (Aβ-PET) in...